Filing Details

Accession Number:
0001209191-14-019320
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-03-11 16:47:11
Reporting Period:
2014-03-07
Filing Date:
2014-03-11
Accepted Time:
2014-03-11 16:47:11
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1509190 Aratana Therapeutics Inc. PETX Pharmaceutical Preparations (2834) 383826477
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1473930 Todd Foley C/O Mpm Asset Management
200 Clarendon Street, 54Th Floor
Boston MA 02116
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2014-03-07 12,539 $19.95 0 No 4 S Indirect By The Todd Foley Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By The Todd Foley Trust
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 3,351,048 Indirect See Footnote
Footnotes
  1. Form 4 filed on March 5, 2014 incorrectly reported the shares held by The Todd Foley Trust as 12,393. The actual number of shares acquired on March 3, 2014 was 12,539.
  2. The price in Column 4 is a weighted average sale price. The prices actually received ranged from $19.94 to $19.95. The Reporting Person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  3. The shares are held as follows: 3,225,494 by MPM BioVentures V, L.P. ("BV V") and 125,554 by MPM Asset Management Investors BV5 LLC ("AM BV5"). MPM BioVentures V GP LLC and MPM BioVentures V LLC ("BV LLC") are the direct and indirect general partners of BV V and BV LLC is the manager of AM BV5. The Reporting Person is a member of BV LLC. The Reporting Person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.